| USF Diabetes Center Home |
|---|
| Clinical Care |
| Diabetes Education |
| Research |
| Living With Diabetes |
| Opportunities and Resources |
| Information for Professionals |
| Youth Zone! |
| About Us |
 |
| The Messenger: Newsletter of the USF Diabetes Center |
 |
 Find us on Facebook! |
For More Information Contact:Craig Bobik, MPH Join the Contact RegistryJoin the USF Diabetes Center Contact Registry to learn more about diabetes research opportunities, events, education and services! Receive the most current information on:
|
Current Studies Offered at the USF Diabetes Center
Established Type 1 Diabetes (diagnosed 3 or more years ago)
T1D Exchange Registry- ACTIVELY RECRUITING
Family Members of People with Diabetes
TrialNet Pathway to Prevention (Natural History) Study- ACTIVELY RECRUITING
TrialNet Oral Insulin Study- If determined to be at risk from the Natural History Study
TrialNet Anti-CD3 Study- If determined to be at risk from the Natural History Study
Newly Diagnosed Type 1 Diabetes
Coming soon to USF Diabetes Center.
Studies at the University of Florida Diabetes Center
Type 2 Diabetes
Studies are being conducted in children with type 2 diabetes using common treatment medications currently approved in adults. The hope is that these medications will also be safe and effective in children.
TrialNet Pathway to Prevention Study
TrialNet is screening relatives of people with Type 1 diabetes to find out if these family members are at risk for developing diabetes. Relatives of people with Type 1 diabetes have about a 3-4 percent chance of testing positive for auto antibodies associated with diabetes. If you learn you are at risk for developing Type 1 Diabetes, additional testing will be offered to estimate your chances of developing Type 1 diabetes. If you qualify, you may have an opportunity to be enrolled in either a Natural History or Prevention Study. All research volunteers will be closely monitored for early detection of Type 1 Diabetes. Early detection of Type 1 Diabetes may improve your blood sugar control and reduce your chances of developing complications. You will be part of a research program that may help other people at risk for Type 1 Diabetes.
Who can participate?
- Individuals who are 1-45 years of age with a parent, child, brother, or sister with Type 1 Diabetes
- Individuals who are 1-20 years of age with a niece, nephew, aunt, uncle, grandparent, half-sibling or cousin with Type 1 Diabetes.
- Note: A relative diagnosed before the age of 40 AND started on insulin within the first year of diagnosis probably has Type 1 Diabetes.
What will study participants be asked to do?
Screening involves a simple blood test for the presence of diabetes-related auto antibodies that may appear years before Type 1 Diabetes develops.
THIS STUDY IS ACTIVELY RECRUITING!
www.diabetestrialnet.org and www.usfdiabetescenter.org
Oral Insulin Study
TrialNet is now testing oral insulin (insulin taken by mouth, not by injection). We will assess whether or not oral insulin helps to delay or prevent Type 1 Diabetes. Results from a recently completed study (DPT-1) suggest that oral insulin might delay or prevent type 1 diabetes in some people found to be at risk.
Who can participate?
Screening to determine eligibility for this study is done through the TrialNet Natural History Study.
What will study participants be asked to do?
You will take one study capsule each day.
- Half the people will take capsules filled with insulin
- Half the people will take a placebo (capsules that contain an inactive ingredient)
- You will not know whether your capsules contain insulin or placebo.
You will come to the study center for blood test every 6 months and at other times as needed.
www.diabetestrialnet.org and www.usfdiabetescenter.org
T1D Exchange Clinical Registry
The T1D Exchange study will help us to learn more about Type 1 Diabetes to improve diabetes treatment, management, and care. We are currently looking for individuals of all ages with T1D to join the T1D Exchange Registry.
Who can join?
People of any age with a clinical diagnosis of Type 1 Diabetes can join.
What will study participants be asked to do?
- The Registry will collect information about your diabetes and your health that is recorded in your medical chart. In addition, you will complete a form with questions about your diabetes, health, and background.
- There are no extra visits in beyond your usual clinic visits, and no blood tests or clinical procedures are required.
- In the future, we plan to have a T1D Exchange social networking and data collection website that you will have the option to join.
Why do we need YOU?
YOU are the expert on your own day-to-day diabetes, so we want to learn from
YOU. We think your information, straight from you, might be the key to understanding more aspects of the disease that we do not yet understand. We hope to learn whether some ways of managing T1D are better than other ways. Having information about people with T1D together in one database, will allow us to review information as never before.
Who is involved in this project?
More than 50 diabetes centers across the United States are participating in this registry. In the future, it is hoped that centers in other countries will participate too. The goal is to enroll 45,000 individuals with T1D in the registry. The Jaeb Center for Health Research in Tampa is the coordinating center for the T1D Exchange and the Leona M. and Harry B. Helmsley Charitable Trust has provided the funding for the project.